A Missouri Senate panel has advanced legislation that could lower costs for some cancer patients.
Bills endorsed by the Senate insurance committee would require insurance companies to charge patients the same out-of-pocket costs for chemotherapy pills as they do for intravenous chemotherapy treatments.
Patients often currently are charged much more for oral chemotherapy. That’s because it is handled as a pharmacy benefit while intravenous treatments often trigger only a standard co-payment for an office visit.
Twenty-seven states and the District of Columbia already have enacted laws requiring equal coverage for oral and intravenous chemotherapy treatments.
The Missouri legislation now goes to the full Senate. A similar proposal is pending in a House committee.
The chemotherapy bills are SB66 and SB668.
Topics Missouri
Was this article valuable?
Here are more articles you may enjoy.
How One Florida Gas Station Worker Allegedly Defrauded Progressive of $44,700 
Four Patients Affected, One Paralyzed, After Drug Mix-Up at Nashville Hospital 
Judge Approves $117.5 Million Settlement in ‘Complex’ Comcast Data Breach Case 
Londoners Find ‘Horrendous’ Cracks in Their Homes After Successive Heat Waves 
